en 12 cuotas de con 0% interés

Publicación pausada

Vendido por US NOCNOC-COR

MercadoLíder Platinum

¡Uno de los mejores del sitio!

+10mil

Ventas concretadas

Brinda buena atención

Entrega sus productos a tiempo

Características del producto

Ancho: 0 cm

Marca: Alcon

Características principales

Marca
Alcon
Modelo
Alcon

Otros

Ancho x Largo
0 cm x 0 cm

Descripción

Key Features -------------------- - Provides temporary relief from redness and itching in the eyes caused by allergens such as pollen, ragweed, and animal dander. - Combines an antihistamine (Pheniramne Malate) and a redness reliever (Naphazoline Hydrochloride) for effective symptom relief. - Suitable for adults and children aged 6 and over, with convenient dropper application. - Sterile formulation ensures safety with each use. - Clinically proven effectiveness for addressing eye allergy symptoms. Fact Sheet -------------------- - Active Ingredients: Naphazoline Hydrochloride 0.025%, Pheniramne Malate 0.3% - Inactive Ingredients: Benzalkonium Chloride, Boric Acid, Edetate Disodium, Purified Water, Sodium Borate, Sodium Chloride, Sodium Hydroxide and/or Hydrochloric Acid. - Dosage: Adults and children over 6 years: 1-2 drops in each affected eye up to 4 times per day. - Storage: Store at 20-25 degrees C (68-77 degrees F), protect from light. Naphcon-A Eye Drops from Alcon provide swift relief for those suffering from seasonal allergies. Designed to alleviate redness and itching, these eye drops help combat eye discomfort due to common irritants like grass, ragweed, and pet dander. The unique combination of Naphazoline and Pheniramine works effectively to soothe and refresh, ensuring your eyes feel their best. With a user-friendly dropper for precise application, Naphcon-A is perfect for adults and children over six. Remember to remove contact lenses before use and be sure to follow the dosage guidelines for optimal results. Keep these essential eye drops handy to tackle allergy season and maintain your comfort throughout the day.

Preguntas y respuestas

Nadie ha hecho preguntas todavía.

¡Haz la primera!